Locametz
Product Images NDC 69488-017

4 FDA label images from Advanced Accelerator Applications Usa, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Locametz (NDC 69488-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Accelerator Applications Usa, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Reconstitution Procedure For Eckert & Ziegler Galliapharm Generator (Psma11 01)

Figure 1. Reconstitution Procedure For Eckert & Ziegler Galliapharm Generator (Psma11 01)
Flowchart illustration showing the preparation process for gallium Ga 68 gozototide from a Gallium-68/Germanium-68 GalliaPharm generator. Steps include elution with 0.1 N HCl solution, lyophilisation, incubation at 20-30°C, activity measurement, pH and radiochemical purity testing, and a final conformity check with acceptance criteria for the gallium Ga 68 gozototide product.*
FDA Label Image

Figure 2. Reconstitution Procedure For Ire Elit Galli Eo Generator (Psma11 02)

Figure 2. Reconstitution Procedure For Ire Elit Galli Eo Generator (Psma11 02)
A flowchart illustrating the preparation and quality control process for gallium Ga 68 gozetotide. It starts with a 68Ge/68Ga GalliAd/GalliEo Generator producing 1.1 mL 68GaCl3 eluate, which reacts with lyophilisate. The process includes vacuum vial venting, incubation at 20-30°C for 5 minutes, activity measurement, and testing of appearance, pH, and radiochemical purity by ITLC. Samples passing the test proceed to a final conformity check with acceptance criteria; those failing are discarded.*
FDA Label Image

Figure 3. Chemical Structure Of Gozetotide (Psma11 03)

Figure 3. Chemical Structure Of Gozetotide (Psma11 03)
Chemical structure of the active ingredient in LOCAMETZ by Advanced Accelerator Applications USA, Inc. The diagram shows the molecular structure featuring gallium (Ga) coordination with surrounding organic ligands.*
FDA Label Image

Principal Display Panel Locametz® Kit For The Preparation Of Gallium Ga 68 Gozetotide Injection 25 Mcg Per Vial Gozetotide For Intravenous Use Only Radiolabel With Gallium-68 Chloride Before Use Rx-only Ndc 69488-017-61 Advanced Accelerator Applications Usa, Inc. Millburn, Nj 07041 (Psma11 04)

Principal Display Panel							Locametz®							Kit For The Preparation Of Gallium Ga 68 Gozetotide Injection 25 Mcg Per Vial Gozetotide							For Intravenous Use Only							Radiolabel With Gallium-68 Chloride Before Use							Rx-only							Ndc 69488-017-61							Advanced Accelerator Applications Usa, Inc. Millburn, Nj 07041 (Psma11 04)
LOCAMETZ kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg per vial, displayed as an unfolded carton label. The label includes storage and handling instructions, mentions the need for reconstitution with gallium-68 chloride solution from a germanium-68/gallium-68 generator, and states it is for intravenous use only. Labeler is Advanced Accelerator Applications USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.